# LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
> **NDA200244** · New Drug Application · Sponsor: HETERO DRUGS LTD · Approved 2010-09-10
## Drug
- **FDA Application Number:** NDA200244
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; NEVIRAPINE; STAVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HETERO DRUGS LTD
- **First approval:** 2010-09-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200244)
---
*MORVS · CC0 1.0*